<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:hpo ids='HP_0003074'>Hyperglycemia</z:hpo> and <z:hpo ids='HP_0000822'>hypertension</z:hpo> are known to be risk factors for the development of <z:hpo ids='HP_0000093'>proteinuria</z:hpo> in patients with <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Little is known, however, about predictors of progression of <z:hpo ids='HP_0000083'>renal failure</z:hpo> in diabetic patients </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: We investigated factors affecting progression of <z:hpo ids='HP_0000083'>renal failure</z:hpo> by measuring the doubling of serum <z:chebi fb="0" ids="16737">creatinine</z:chebi> (s-Cr) as an end point in a cohort of 85 type 2 diabetic patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0000083'>renal insufficiency</z:hpo>/failure (s-Cr &gt;1.5 and &lt;3.7 mg/dl, 61 +/- 11 years old, 51 men and 34 women, mean s-Cr 2.3 +/- 0.6 mg/dl) </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The survey period (mean +/- SD) was 14.2 +/- 10.8 months </plain></SENT>
<SENT sid="4" pm="."><plain>The cumulative incidence of the end point in patients with insulin therapy (n = 41) was significantly lower than that in patients without it (n = 44) (P = 0.0022, P values by log-rank test) </plain></SENT>
<SENT sid="5" pm="."><plain>Multivariate Cox analysis revealed insulin therapy (hazard ratio [HR] 0.435, 95% CI 0.252-0.750, P = 0.0027), serum albumin (0.484, 284-0.823, P = 0.0074), mean blood pressure (1.023, 1.004-1.043, P = 0.017), and <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> (0.841, 0.728-0.972, P = 0.0194) to be independent and significant predictors of progression to <z:hpo ids='HP_0000083'>renal failure</z:hpo>, whereas HbA(1c) or serum cholesterol were not </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: In type 2 diabetic patients with <z:hpo ids='HP_0000083'>renal failure</z:hpo>, <z:hpo ids='HP_0003073'>hypoalbuminemia</z:hpo>, <z:hpo ids='HP_0001903'>anemia</z:hpo>, higher mean blood pressure, and lack of use of insulin predict <z:hpo ids='HP_0003678'>rapid progression</z:hpo> of <z:hpo ids='HP_0000083'>renal failure</z:hpo>, but HbA(1c) does not, and insulin therapy may be possibly an indicator of the delay in progression of <z:hpo ids='HP_0000083'>renal failure</z:hpo> </plain></SENT>
</text></document>